As of 2026-02-13, the Relative Valuation of Rapid Dose Therapeutics Corp (DOSE.CN) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.16 CAD, the upside of Rapid Dose Therapeutics Corp based on Relative Valuation is -107.0%.
The range of the Relative Valuation is (0.01) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.3x - 0.4x | 0.4x |
| Forward P/E multiples | 0.2x - 0.4x | 0.3x |
| Fair Price | (0.01) - (0.01) | (0.01) |
| Upside | -106.0% - -107.7% | -107.0% |
| Date | P/E |
| 2026-02-05 | -4.21 |
| 2026-02-04 | -4.07 |
| 2026-02-03 | -4.07 |
| 2026-02-02 | -4.07 |
| 2026-01-29 | -4.21 |
| 2026-01-28 | -4.21 |
| 2026-01-26 | -4.07 |
| 2026-01-22 | -4.21 |
| 2026-01-21 | -4.50 |
| 2026-01-20 | -4.36 |
| 2026-01-19 | -4.21 |
| 2026-01-16 | -4.65 |
| 2026-01-15 | -4.07 |
| 2026-01-14 | -3.92 |
| 2026-01-13 | -3.78 |
| 2026-01-12 | -4.21 |
| 2026-01-08 | -3.92 |
| 2026-01-07 | -3.78 |
| 2026-01-06 | -4.21 |
| 2026-01-05 | -4.21 |
| 2026-01-02 | -4.07 |
| 2025-12-31 | -3.78 |
| 2025-12-30 | -3.78 |
| 2025-12-29 | -3.92 |
| 2025-12-24 | -4.07 |
| 2025-12-22 | -3.78 |
| 2025-12-19 | -4.21 |
| 2025-12-18 | -3.92 |
| 2025-12-17 | -4.07 |
| 2025-12-16 | -4.21 |
| 2025-12-15 | -4.50 |
| 2025-12-12 | -4.65 |
| 2025-12-09 | -4.50 |
| 2025-12-08 | -4.50 |
| 2025-12-05 | -4.50 |
| 2025-12-04 | -4.65 |
| 2025-11-28 | -4.65 |
| 2025-11-26 | -4.94 |
| 2025-11-24 | -4.94 |
| 2025-11-21 | -5.52 |
| 2025-11-20 | -4.94 |
| 2025-11-19 | -5.23 |
| 2025-11-18 | -4.65 |
| 2025-11-17 | -4.65 |
| 2025-11-14 | -4.65 |
| 2025-11-12 | -4.36 |